Interleukin-1 Receptor Antagonist [EPC]

16150 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 5068
1 DRUG INEFFECTIVE 4184
2 CONDITION AGGRAVATED 1652
3 PAIN 1569
4 RHEUMATOID ARTHRITIS 1542
5 JOINT SWELLING 1187
6 ARTHRALGIA 1183
7 DRUG INTOLERANCE 1164
8 PYREXIA 1138
9 INJECTION SITE PAIN 1005
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 302 0.9042
1 INFILTRATION ANAESTHESIA 22 0.6875
2 ACTINOMYCOTIC SEPSIS 17 0.6800
3 HUMAN ANTI-HUMAN ANTIBODY TEST 16 0.5926
4 BODY HEIGHT BELOW NORMAL 311 0.4844
5 CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME 9 0.4500
6 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 11 0.3667
7 ALPHA TUMOUR NECROSIS FACTOR INCREASED 30 0.3226
8 SERUM AMYLOID A PROTEIN INCREASED 46 0.3067
9 ANKLE ARTHROPLASTY 97 0.2795
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]